Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2006;332:443 (25 February), doi:10.1136/bmj.332.7539.443
London Michael Day
The UK government has again clashed with the House of Lords over the readiness of the country’s vaccine manufacturers to deal with an epidemic of avian influenza in humans.
In December, in its report on epidemic flu, the House of Lords Science and Technology Select Committee said that ministers should “follow the example of the US in making a major investment in developing new vaccination techniques” (BMJ 2006;332:8, 7 Jan).
It also called on the government to encourage vaccine manufacturers to allow the “free exchange” of new technologies so that a vaccine may be produced as quickly as possible.
However, last week the Department of Health, in its official response to the report, said it was up to industry and not the government to prepare for the speedy mass production of a vaccine against bird flu.
The department said that vaccine manufacturers were “fully cognisant” of
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
StumbleUpon
Technorati What's this?